Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 63 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00312975Phase 2
• Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)TerminatedNCT00310232Phase 3
• Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00310154Phase 1
• Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00309998Phase 2
• Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00309972Phase 3
• Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung CancerCompletedNCT00305617Not applicable
• Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving ChemotherapyStatus unknownNCT00300729Phase 3
• IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00300586Phase 3
• Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00298415Phase 3
• A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung CancerCompletedNCT00297089Phase 1/2
• Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryTerminatedNCT00293332Phase 2
• Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00293280Phase 2
• An Open, Randomized, Multicentre, Phase II Pilot StudyCompletedNCT00293085Phase 2
• Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLCTerminatedNCT00291850Phase 2
• A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)TerminatedNCT00290550Phase 2
• Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyTerminatedNCT00290017Phase 3
• Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004Status unknownNCT00285675Phase 2
• Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung CancerCompletedNCT00284778Phase 3
• A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung CancerTerminatedNCT00283634Phase 2
• Iscar for Second Line Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT00283478Not applicable
• Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By SurgeryCompletedNCT00281970Phase 2
• Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung CancerTerminatedNCT00281125Phase 1/2
• Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With PegfilgrastimCompletedNCT00280787Phase 2
• Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00278460Phase 2
• Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00278187Phase 2
• Metronomic Oral Vinorelbine in Patients With Metastatic TumorsCompletedNCT00278070Phase 2
• Study of XL999 in Patients With Non-small Cell Lung CancerTerminatedNCT00277329Phase 2
• Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00276588Phase 2
• Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung CancerStatus unknownNCT00274898Phase 2
• An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With CarboplatinCompletedNCT00274443Phase 2
• Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3TerminatedNCT00273507Phase 3
• Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2Status unknownNCT00273494Phase 3
• Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC PatientsTerminatedNCT00271323Phase 2
• Efficacy Study of GEMOX Combination and Vinorelbine in NSCL PatientsCompletedNCT00271271Phase 2
• A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung CancerStatus unknownNCT00270582Phase 2
• Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00268970Phase 2
• Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLCStatus unknownNCT00268684Phase 3
• Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00268489Phase 2
• Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung CancerWithdrawnNCT00268255Phase 1/2
• Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung CancerTerminatedNCT00268151Phase 1
• Random Trial for Elderly Patients With NSCLCStatus unknownNCT00265694Phase 3
• Safety Study: Combined Modality Treatment for Non-Small Cell Lung CancerTerminatedNCT00265603Phase 1
• Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung CancerTerminatedNCT00264134Phase 1/2
• Metabolomic Analysis of Lung CancerCompletedNCT00263731
• Docetaxel in Non Small Cell Lung Cancer (NSCLC)TerminatedNCT00263016Phase 2
• LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung CancerTerminatedNCT00260598Phase 2
• Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung CancerCompletedNCT00260026Phase 2
• Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLCCompletedNCT00259675Phase 2
• Iressa v BSC (Best Supportive Care) in First Line NSCLCCompletedNCT00259064Phase 2/3
• Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination ChemotherapyWithdrawnNCT00256841Phase 1/2
• Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I StudyCompletedNCT00256815Phase 1/2
• Once Weekly Radiation for Lung Cancer With ChemotherapyCompletedNCT00256789Not applicable
• Phase II Iressa Versus Vinorelbine (INVITE)CompletedNCT00256711Phase 2
• A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung CancerCompletedNCT00255489Phase 1
• Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLCTerminatedNCT00254904Phase 3
• Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00254891Phase 3
• Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following SurgeryCompletedNCT00254384Phase 1
• Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT00254319Phase 2
• Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00253591Phase 2/3
• ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung CancerCompletedNCT00252798Phase 1
• Iressa Case Control Study in JapanCompletedNCT00252759
• ZD6474 Phase IIa Dose Finding Multicentre StudyCompletedNCT00252746Phase 2
• Iressa 2nd Line Phase III Study in JapanCompletedNCT00252707Phase 3
• A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLCCompletedNCT00251524Phase 2
• Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00251498Phase 2
• A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT00251446Phase 2
• Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLCCompletedNCT00250978Phase 1
• Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung CancerStatus unknownNCT00246727Phase 3
• Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLCCompletedNCT00246181Phase 1/2
• Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung CancerCompletedNCT00246116Not applicable
• Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00245154Phase 2/3
• Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyTerminatedNCT00243204Phase 3
• Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung CancerStatus unknownNCT00242983
• A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)CompletedNCT00238875Phase 2
• Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.Status unknownNCT00238849Phase 2
• Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain MetastasesCompletedNCT00238251Phase 2
• Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLCTerminatedNCT00234468Phase 3
• Iressa in the Treatment of Brain Metastases From Non Small Cell Lung CancerTerminatedNCT00234442Phase 2
• Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung CancerTerminatedNCT00232206Phase 2
• Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu VaccineCompletedNCT00228358Phase 1
• Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00227708Phase 2
• Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"CompletedNCT00222404
• Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung CancerCompletedNCT00221169Early Phase 1
• Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung CancerCompletedNCT00219297Phase 2
• Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00217698Phase 2
• Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung CancerCompletedNCT00217282Phase 2
• Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer PatientsCompletedNCT00213798Not applicable
• Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung CancerCompletedNCT00213733
• Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell CarcinomaCompletedNCT00212043Phase 2
• Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC PatientsSuspendedNCT00211952Phase 3
• Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung CancerWithdrawnNCT00210171Phase 2
• An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung CarcinomaCompletedNCT00207116Phase 1
• OSI-774 (Erlotinib, Tarceva) in Elderly PatientsCompletedNCT00200395Phase 2
• Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung CancerTerminatedNCT00200382Phase 2
• Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung CancerCompletedNCT00199758Phase 2
• Follow-up of Patients With Curative-intent Surgical Resection for NSCLCCompletedNCT00199615Not applicable
• Chemoradiotherapy of NSCLC Stage IIIBCompletedNCT00198432Phase 2
• Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IVCompletedNCT00198393Phase 2
• Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00198367Phase 2
• Stage I/II NSCLC Perioperative ChemotherapyCompletedNCT00198354Phase 3

← Carcinoma, Non-Small-Cell Lung overview